B-cell responses to myelin basic protein and its epitopes in autoimmune encephalomyelitis induced by Semple rabies vaccine

Journal of Neuroimmunology

Volumn 98, Issue 2, 1999, Pages 96-104

  Piyasirisilp, Sucheep ^a   Hemachudha, Thiravat ^b   Griffin, Diane E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

Encephalomyelitis, acute disseminated; Epitopes, B lymphocyte; Immunoglobulin class switching; Multiple sclerosis; Myelin basic proteins

Indexed keywords

ANTIBODY; EPITOPE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MYELIN BASIC PROTEIN; RABIES VACCINE;

ADULT; ALLERGIC ENCEPHALOMYELITIS; AMINO ACID SEQUENCE; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DEMYELINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HELPER CELL; HUMAN; HUMAN CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANIMALS; ANTIBODY SPECIFICITY; AUTOANTIGENS; B-LYMPHOCYTES; BRAIN CHEMISTRY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; GOATS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; RABIES VACCINES; SHEEP; TH1 CELLS;

EID: 0033052979     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00065-X     Document Type: Article

References (51)

1. Abbas, A.K., Lichtman, A.H., Pober, J.S., 1994. Regulation of immune responses. Cellular and Molecular Immunology. Saunders, Philadelphia, PA, pp. 206-221.
2. Aebischer I., Stadler B.M. TH1-TH2 cells in allergic responses: at the limits of a concept. Adv. Immunol. 61:1996;341-403.
3. Al-Din A.S., Al-Saffar M., Siboo R., Behbehani K. Association between HLA-D region epitopes and multiple sclerosis in Arabs. Tissue Antigens. 27:1986;196-200.
4. Brosnan C.F., Bornstein M.B., Bloom B.R. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J. Immunol. 126:1981;614-620.
5. Bruggemann M.G., Williams G.T., Bindon C.I., Clark M.R., Walker M.R., Jefferis R., Waldmann H., Neuberger M.S. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J. Exp. Med. 166:1987;1351-1361.
6. Brunner C., Lassmann H., Waehneldt T.V., Matthieu J.M., Linington C. Differential ultrastructural localization of myelin basic protein, myelin oligodendroglial glycoprotein, and 2′,3′-cyclic nucleotide 3′-phosphodiesterase in the CNS of adult rats. J. Neurochem. 52:1989;296-304.
7. Dangl J.L., Wensel T.G., Morrison S.L., Stryer L., Herzenberg L.A., Oi V.T. Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J. 7:1988;1989-1994.
8. Deibler G.E., Martenson R.E., Kies M.W. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2:1972;139-165.
9. Eng L.F., Ghirnikar R.S., Lee Y.L. Inflammation in EAE: role of chemokine/cytokine expression by resident and infiltrating cells. Neurochem. Res. 21:1996;511-525.
10. Fields, G.B., Tian, Z., Barany, G., 1992. Principles and practice of solid-phase peptide synthesis. In: Grant, G.A. (Ed.), Synthetic Peptides: A User's Guide. Freeman, New York, pp. 77-183.
11. Gearhart, P.J., 1993. Somatic mutation and affinity maturation. In: Paul, W.E. (Ed.), Fundamental Immunology. Raven Press, New York, pp. 865-885.
12. Genain C.P., Cannella B., Hauser S.L., Raine C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5:1999;170-175.
13. Griffin, D.E., Hemachudha, T., Johnson, R.T., 1989. Postinfectious and postvaccinal encephalomyelitis. In: Gilden, D.H., Lipton, H.L. (Eds.), Clinical and Molecular Aspects of Neurotropic Virus Infection. Kluwer, Norwell, pp. 501-527.
14. Hauser S.L., Fleischnick E., Weiner H.L., Marcus D., Awdeh Z., Yunis E.J., Alper C.A. Extended major histocompatibility complex haplotypes in patients with multiple sclerosis. Neurology. 39:1989;275-277.
15. Hemachudha T., Phanuphak P., Johnson R.T., Griffin D.E., Ratanavongsiri J., Siriprasomsup W. Neurologic complications of Semple-type rabies vaccine: clinical and immunologic studies. Neurology. 37:1987;550-556.
16. Hemachudha T., Griffin D.E., Giffels J.J., Johnson R.T., Moser A.B., Phanuphak P. Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. N. Engl. J. Med. 316:1987;369-374.
17. Huitinga I., van Rooijen N., de Groot C.J., Uitdehaag B.M., Dijkstra C.D. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 172:1990;1025-1033.
18. Ichikawa M., Johns T.G., Adelmann M., Bernard C.C. Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein-derived peptides. Int. Immunol. 8:1996;1667-1674.
19. Ingelfinger, J.A., Mosteller, F., Thibodeau, L.A., Ware, J.H., 1987. What are P values? Biostatistics in Clinical Medicine. Macmillan, New York, pp. 151-167.
20. Johns T.G., Kerlero de Rosbo N., Menon K.K., Abo S., Gonzales M.F., Bernard C.C. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J. Immunol. 154:1995;5536-5541.
21. Kabat E.A. Heterogeneity and structure of antibody-combining sites. Ann. N.Y. Acad. Sci. 169:1970;43-54.
22. Kerlero de Rosbo N., Honegger P., Lassmann H., Matthieu J.M. Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin oligodendrocyte glycoprotein. J. Neurochem. 55:1990;583-587.
23. Kerlero de Rosbo N., Hoffman M., Mendel I., Yust I., Kaye J., Bakimer R., Flechter S., Abramsky O., Milo R., Karni A., Ben-Nun A. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions. Eur. J. Immunol. 27:1997;3059-3069.
24. Lassmann, H., Linington, C., 1987. The role of antibodies against myelin surface antigens in demyelination in chronic EAE. In: Crescenzi, G.S. (Ed.), A Multidisciplinary Approach to Myelin Diseases. Plenum, New York, pp. 219-225.
25. Lassmann H., Sternberger H., Kitz K., Wisniewski H.M. In vivo demyelinating activity of sera from animals with chronic experimental allergic encephalomyelitis. Antibody nature of the demyelinating factor and the role of complement. J. Neurol. Sci. 59:1983;123-137.
26. Lassmann, H., Suchanek, G., Kitz, K., Sternberger, H., Schwerer, B., Bernheimer, H., 1984. Antibodies in the pathogenesis of demyelination in chronic relapsing EAE. In: Alvord, E.C., Kies, M.W., Suckling, A.J. (Eds.), Experimental Allergic Encephalomyelitis: A Useful Model For Multiple Sclerosis. Alan R. Liss, New York, pp. 165-170.
27. Lassmann H., Brunner C., Bradl M., Linington C. Experimental allergic encephalomyelitis: the balance between encephalitogenic T-lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol. Berlin. 75:1988;566-576.
28. Liblau R.S., Singer S.M., McDevitt H.O. Th1 and Th2 CD4+ T-cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today. 16:1995;34-38.
29. Linington C., Bradl M., Lassmann H., Brunner C., Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin oligodendrocyte glycoprotein. Am. J. Pathol. 130:1988;443-454.
30. Myers K.J., Sprent J., Dougherty J.P., Ron Y. Synergy between encephalitogenic T-cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 41:1992;1-8.
31. Olsson T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144:1995;245-268.
32. Olsson T., Baig S., Hojeberg B., Link H. Anti-myelin basic protein and anti-myelin antibody-producing cells in multiple sclerosis. Ann. Neurol. 27:1990;132-136.
33. Piddlesden S., Lassmann H., Laffafian I., Morgan B.P., Linington C. Antibody-mediated demyelination in experimental allergic encephalomyelitis is independent of complement membrane attack complex formation. Clin. Exp. Immunol. 83:1991;245-250.
34. Piddlesden S.J., Lassmann H., Zimprich F., Morgan B.P., Linington C. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am. J. Pathol. 143:1993;555-564.
35. Piyasirisilp, S., Schmeckpeper, B.J., Chandanayingyong, D., Hemachudha, T., Griffin, D.E., in press. Association of HLA and T-cell receptor gene polymorphisms with Semple rabies vaccine-induced autoimmune encephalomyelitis. Ann. Neurol.
36. Rivers T.M., Schwentker F.F. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J. Exp. Med. 61:1935;689-702.
37. Roth H.J., Kronquist K.E., Kerlero de Rosbo N., Crandall B.F., Campagnoni A.T. Evidence for the expression of four myelin basic protein variants in the developing human spinal cord through cDNA cloning. J. Neurosci. Res. 17:1987;321-328.
38. Schechter I. Mapping of the combining sites of antibodies specific to polyalanine chains. Ann. N.Y. Acad. Sci. 190:1971;394-419.
39. Serjeantson S.W., Gao X., Hawkins B.R., Higgins D.A., Yu Y.L. Novel HLA-DR2-related haplotypes in Hong Kong Chinese implicate the DQB1*0602 allele in susceptibility to multiple sclerosis. Eur. J. Immunogenet. 19:1992;11-19.
40. Stavnezer J. Antibody class switching. Adv. Immunol. 61:1996;79-146.
41. Sun J.B., Olsson T., Wang W.Z., Xiao B.G., Kostulas V., Fredrikson S., Ekre H.P., Link H. Autoreactive T- and B-cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur. J. Immunol. 21:1991;1461-1468.
42. Sun J., Link H., Olsson T., Xiao B.G., Andersson G., Ekre H.P., Linington C., Diener P. T- and B-cell responses to myelin oligodendrocyte glycoprotein in multiple sclerosis. J. Immunol. 146:1991;1490-1495.
43. Takacs K., Kalman B., Gyodi E., Tauszik T., Palffy G., Kuntar L., Guseo A., Nagy C., Petranyi G. Association between the lack of HLA-DQw6 and the low incidence of multiple sclerosis in Hungarian Gypsies. Immunogenetics. 31:1990;383-385.
44. Ubol S., Hemachudha T., Whitaker J.N., Griffin D.E. Antibody to peptides of human myelin basic protein in postrabies vaccine encephalomyelitis sera. J. Neuroimmunol. 26:1990;107-111.
45. Waldmann H. Manipulation of T-cell responses with monoclonal antibodies. Annu. Rev. Immunol. 7:1989;407-444.
46. Warren K.G., Catz I., Johnson E., Mielke B. Anti-myelin basic protein and anti-proteolipid protein-specific forms of multiple sclerosis. Ann. Neurol. 35:1994;280-289.
47. Warren K.G., Catz I., Steinman L. Fine specificity of the antibody response to myelin basic protein in the central nervous system in multiple sclerosis: the minimal B-cell epitope and a model of its features. Proc. Natl. Acad. Sci. USA. 92:1995;11061-11065.
48. Wekerle H., Kojima K., Lannes-Vieira J., Lassmann H., Linington C. Animal models. Ann. Neurol. 36:1994;S47-53.
49. Wilkinson, L., 1996. SYSTAT™ 6.0 for Windows™: Graphics. SPSS, Chicago, pp. 104-108.
50. Wucherpfennig K.W., Catz I., Hausmann S., Strominger J.L., Steinman L., Warren K.G. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T-cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes. J. Clin. Invest. 100:1997;1114-1122.
51. Zamvil S.S., Steinman L. The T-lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8:1990;579-621.